ITRM950589A0 - Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire malattie causate dalla sovrapproduzione di dette citochine naturali, e composizioni farmaceutiche cosi' ottenibili - Google Patents

Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire malattie causate dalla sovrapproduzione di dette citochine naturali, e composizioni farmaceutiche cosi' ottenibili

Info

Publication number
ITRM950589A0
ITRM950589A0 ITRM950589A ITRM950589A ITRM950589A0 IT RM950589 A0 ITRM950589 A0 IT RM950589A0 IT RM950589 A ITRM950589 A IT RM950589A IT RM950589 A ITRM950589 A IT RM950589A IT RM950589 A0 ITRM950589 A0 IT RM950589A0
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
natural
overproduction
immunogens
obtainable
Prior art date
Application number
ITRM950589A
Other languages
English (en)
Inventor
Gennaro Ciliberto
Rocco Savino
Original Assignee
Gennaro Ciliberto
Rocco Savino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gennaro Ciliberto, Rocco Savino filed Critical Gennaro Ciliberto
Publication of ITRM950589A0 publication Critical patent/ITRM950589A0/it
Priority to IT95RM000589A priority Critical patent/IT1277926B1/it
Priority to DK96930345T priority patent/DK0858345T3/da
Priority to AT96930345T priority patent/ATE226446T1/de
Priority to JP51104897A priority patent/JP3157837B2/ja
Priority to PT96930345T priority patent/PT858345E/pt
Priority to PCT/IT1996/000164 priority patent/WO1997009064A1/en
Priority to MX9801550A priority patent/MX9801550A/es
Priority to DE69624498T priority patent/DE69624498T2/de
Priority to CNB961972955A priority patent/CN1138562C/zh
Priority to KR1019980701561A priority patent/KR100279539B1/ko
Priority to AU69428/96A priority patent/AU703300B2/en
Priority to EP96930345A priority patent/EP0858345B1/en
Priority to CA002229045A priority patent/CA2229045C/en
Priority to RU98105679/14A priority patent/RU2182014C2/ru
Priority to ES96930345T priority patent/ES2183007T3/es
Publication of ITRM950589A1 publication Critical patent/ITRM950589A1/it
Application granted granted Critical
Publication of IT1277926B1 publication Critical patent/IT1277926B1/it
Priority to HK99100962A priority patent/HK1015708A1/xx
Priority to US09/559,950 priority patent/US6706261B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
IT95RM000589A 1995-09-01 1995-09-01 Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire IT1277926B1 (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT95RM000589A IT1277926B1 (it) 1995-09-01 1995-09-01 Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
CNB961972955A CN1138562C (zh) 1995-09-01 1996-08-22 野生型细胞因子的突变蛋白作为免疫原的用途
AU69428/96A AU703300B2 (en) 1995-09-01 1996-08-22 Use of muteins of wild-type cytokines as immunogens
JP51104897A JP3157837B2 (ja) 1995-09-01 1996-08-22 免疫原としての野生型サイトカインのミューティンの使用
PT96930345T PT858345E (pt) 1995-09-01 1996-08-22 Uso de muteinas de citocinas do tipo selvagem como imunogenios
PCT/IT1996/000164 WO1997009064A1 (en) 1995-09-01 1996-08-22 Use of muteins of wild-type cytokines as immunogens
MX9801550A MX9801550A (es) 1995-09-01 1996-08-22 Uso de muteinas de citocinas de tipo silvestre como inmunogenos.
DE69624498T DE69624498T2 (de) 1995-09-01 1996-08-22 Muteine von wildtyp-cytokinen und ihre verwendung als immunogene
DK96930345T DK0858345T3 (da) 1995-09-01 1996-08-22 Anvendelse af muteiner af vildtypecytokiner som immunogener
KR1019980701561A KR100279539B1 (ko) 1995-09-01 1996-08-22 야생형 시토킨의 뮤테인의 면역원으로서의 용도
AT96930345T ATE226446T1 (de) 1995-09-01 1996-08-22 Muteine von wildtyp-cytokinen und ihre verwendung als immunogene
EP96930345A EP0858345B1 (en) 1995-09-01 1996-08-22 Use of muteins of wild-type cytokines as immunogens
CA002229045A CA2229045C (en) 1995-09-01 1996-08-22 Use of muteins of wild-type cytokines as immunogens
RU98105679/14A RU2182014C2 (ru) 1995-09-01 1996-08-22 Использование мутеинов цитокинов дикого типа в качестве иммуногенов
ES96930345T ES2183007T3 (es) 1995-09-01 1996-08-22 Empleo de muteinas de citoquinas de tipo salvaje como inmunogenos.
HK99100962A HK1015708A1 (en) 1995-09-01 1999-03-09 Use of muteins of wild-type cytokines as immunogens.
US09/559,950 US6706261B1 (en) 1995-09-01 2000-04-27 Compositions and methods comprising immunogenic muteins of interleukin-6

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000589A IT1277926B1 (it) 1995-09-01 1995-09-01 Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire

Publications (3)

Publication Number Publication Date
ITRM950589A0 true ITRM950589A0 (it) 1995-09-01
ITRM950589A1 ITRM950589A1 (it) 1997-03-01
IT1277926B1 IT1277926B1 (it) 1997-11-12

Family

ID=11403544

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95RM000589A IT1277926B1 (it) 1995-09-01 1995-09-01 Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire

Country Status (17)

Country Link
US (1) US6706261B1 (it)
EP (1) EP0858345B1 (it)
JP (1) JP3157837B2 (it)
KR (1) KR100279539B1 (it)
CN (1) CN1138562C (it)
AT (1) ATE226446T1 (it)
AU (1) AU703300B2 (it)
CA (1) CA2229045C (it)
DE (1) DE69624498T2 (it)
DK (1) DK0858345T3 (it)
ES (1) ES2183007T3 (it)
HK (1) HK1015708A1 (it)
IT (1) IT1277926B1 (it)
MX (1) MX9801550A (it)
PT (1) PT858345E (it)
RU (1) RU2182014C2 (it)
WO (1) WO1997009064A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1226173A1 (en) * 1999-10-07 2002-07-31 Maxygen Aps Single-chain antagonist polypeptides
FR2812813B1 (fr) * 2000-08-09 2004-11-26 Neovacs Utilisation d'immunogenes pour traiter ou prevenir au sein des tumeurs malignes les dereglements immunitaires induits par des facteurs extracellulaires
IL161672A0 (en) * 2004-04-29 2004-09-27 Yeda Res & Dev Compositions and methods for therapy of chemotherapy-induced neuropathy
FR2978964B1 (fr) 2011-08-09 2015-02-20 Conservatoire Nat Arts Composition vaccinale anti-il-6
WO2015024148A1 (zh) * 2013-08-23 2015-02-26 中国科学院微生物研究所 异源动物细胞因子突变体疫苗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677654B1 (fr) 1991-06-17 1995-11-17 Pasteur Merieux Serums Vacc Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.
US5338833A (en) * 1992-07-23 1994-08-16 The University Of North Carolina At Chapel Hill Carboxy terminal IL-6 muteins
IT1263022B (it) * 1992-11-06 1996-07-23 Angeletti P Ist Richerche Bio Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
IT1261787B (it) * 1993-06-23 1996-06-03 Angeletti P Ist Richerche Bio Metodologia per la selezione di superagonisti, antagonisti e super- antagonisti di ormoni del cui complesso recettoriale fa parte gp 130.
WO1997010338A1 (en) 1995-09-12 1997-03-20 Chiron Corporation Improved interleukin-6 receptor antagonist

Also Published As

Publication number Publication date
WO1997009064A1 (en) 1997-03-13
DK0858345T3 (da) 2003-02-24
EP0858345A1 (en) 1998-08-19
CA2229045A1 (en) 1997-03-13
JPH10511111A (ja) 1998-10-27
ES2183007T3 (es) 2003-03-16
AU703300B2 (en) 1999-03-25
KR100279539B1 (ko) 2001-02-01
ITRM950589A1 (it) 1997-03-01
MX9801550A (es) 1998-05-31
DE69624498D1 (de) 2002-11-28
IT1277926B1 (it) 1997-11-12
US6706261B1 (en) 2004-03-16
AU6942896A (en) 1997-03-27
CN1198098A (zh) 1998-11-04
EP0858345B1 (en) 2002-10-23
PT858345E (pt) 2003-02-28
HK1015708A1 (en) 1999-10-22
CN1138562C (zh) 2004-02-18
RU2182014C2 (ru) 2002-05-10
CA2229045C (en) 2005-10-25
KR19990044321A (ko) 1999-06-25
DE69624498T2 (de) 2003-06-18
ATE226446T1 (de) 2002-11-15
JP3157837B2 (ja) 2001-04-16

Similar Documents

Publication Publication Date Title
NZ284846A (en) 1-substituted-pyrazolo[3,4-b]pyridin-5-carboxylic acid derivatives, preparation, use, intermediates and pharmaceutical compositions thereof
DE69028671T2 (de) Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
NZ237041A (en) Substituted 1h-indole derivatives, preparation, pharmaceutical compositions and intermediates thereof
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
SE8804629D0 (sv) New therapeutically active compounds
IT1240360B (it) Uso di un derivato dell'1alfa-idrossivitamina d per la preparazione di un medicamento per il trattamento dell' iperparatiroidismo
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
ITTO920325A0 (it) Nuovi derivati basici dell'acido glutammico ed acido aspartico, proce-dimento per la loro preparazione e loro uso farmaceutico.
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ITMI922331A0 (it) Uso di paratormone suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto protermine ed in generale per il trattamento della gestazione
NO306903B1 (no) 6-(substituert-metylen)-penem'er, farmasöytiske blandinger inneholdende slike, anvendelse derav og mellomprodukter for fremstilling av dem
ITRM20000340A0 (it) Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie cara
ITRM950589A0 (it) Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire malattie causate dalla sovrapproduzione di dette citochine naturali, e composizioni farmaceutiche cosi' ottenibili
IT1297205B1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
IT9019793A0 (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
DK1058544T3 (da) Inhibition af TNF-aktivitet med præparater, der omfatter heparin og oplöselige TNF-receptorer
IT8319219A0 (it) Derivati di arilossipropanolamina, procedimento per la loro preparazione composizioni farmaceutiche cheli contengono e loro impiego terapeutico
EP0351876A3 (en) Composition for potentiating vaccination effect
TR199900013T2 (xx) Yeni bile�ikler.
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
MX9302272A (es) Retinoides solubles en agua.
CA2423288A1 (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
ZA914376B (en) Benzimidazole derivatives,their preparation process,the intermediates obtained,their use as medicaments and the pharmaceutical compositions containing them

Legal Events

Date Code Title Description
0001 Granted